2016
DOI: 10.1124/mol.116.107367
|View full text |Cite
|
Sign up to set email alerts
|

Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts

Abstract: Opioid dependence during pregnancy is a rising concern. Maintaining addicted pregnant women on long-acting opioid receptor agonist is the most common strategy to manage drug abuse in pregnant women. Methadone (MET) and buprenorphine (BUP) are widely prescribed for opiate maintenance therapy. Norbuprenorphine (NBUP) is the primary active metabolite of BUP. These medications can cross the placenta to the fetus, leading to postpartum neonatal abstinence syndrome. Despite their use during pregnancy, little is know… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(15 citation statements)
references
References 58 publications
(62 reference statements)
0
15
0
Order By: Relevance
“…It should be noted that several of the HCV patients reported a history of using drugs of abuse or were prescribed methadone maintenance therapy. A prior report indicated that methadone upregulates BCRP expression in human trophoblasts [24]. However, the HCV samples with the greatest expression levels of BCRP and P-gp were not associated with those patients on methadone maintenance therapy.…”
Section: Discussionmentioning
confidence: 92%
“…It should be noted that several of the HCV patients reported a history of using drugs of abuse or were prescribed methadone maintenance therapy. A prior report indicated that methadone upregulates BCRP expression in human trophoblasts [24]. However, the HCV samples with the greatest expression levels of BCRP and P-gp were not associated with those patients on methadone maintenance therapy.…”
Section: Discussionmentioning
confidence: 92%
“…While there is a consensus that P-gp levels in human placenta decline with gestational age, controversial results exist regarding the changes of BCRP expression in human placenta over gestation [40,71]. P-gp and BCRP expression in the placenta could be regulated at the transcriptional, translational and post-translational levels [79,83,89,136]. Recent studies indicate that the roles of P-gp (likely BCRP as well) in determining fetal drug exposure depend on drugs administered even if the drugs are their substrates, a phenomenon that could be interpreted by the concept of fraction of drug transported [51,56,57,61,80,91,92,95,137,138].…”
Section: Resultsmentioning
confidence: 99%
“…Continuous exposure of BeWo cells to genistein (a dietary isoflavone) for 48 hours reduced the expression of ABCG2 mRNA and protein by up to 40%, and the down-regulation could be attenuated by pharmacological inhibition of the estrogen receptor, suggesting that phytoestrogens may reduce BCRP expression through this hormone receptor pathway in BeWo cells [88]. Buprenorphine, norbuprenorphine, and methadone (narcotic), which are potent AhR agonists, can induce BCRP in human placental trophoblasts by activating AhR [89]. Acetaminophen (analgesic) was found to induce oxidative stress and down-regulate BCRP/Bcrp in human JEG-3 cells or rat placenta [90].…”
Section: P-gp and Bcrp In The Placentamentioning
confidence: 99%
“…Previous studies suggested that the expression of BCRP is tightly regulated, mainly at the transcriptional level with species-specific induction [28,29]. Promoters, which are usually located upstream of a gene, play a decisive role in gene transcription.…”
Section: Discussionmentioning
confidence: 99%